Results 171 to 180 of about 35,907 (256)

Does BRCA Mutation Status Influence Ovarian Cancer Onset Timing and Patients' Treatment Outcomes? [PDF]

Genes (Basel)
Michalczyk K, Mokrzycka A, Rudzińska M, Michalczyk B, Menkiszak J, Chudecka-Głaz A.   +5 more
europepmc   +1 more source

A novel BRCA mutation classification system reveals differential responses to PARP inhibition and prognostic outcomes in epithelial ovarian cancer: a multicenter study. [PDF]

ESMO Open
Liu Q, Fan Y, Huang C, Wu M, Jin Y, Tao L, Liu Y, Song J, Wang S, Kong W, Huang X, Ha C, Cui Z, Zhao D, Yang X, Qiao J, Zhang Y, Li Y, Guo H.   +18 more
europepmc   +1 more source

The impact of BRCA mutation and hormone receptor status on the outcomes of fertility preservation in breast cancer patients: a systematic review and meta-analysis. [PDF]

Front Oncol
Ye L, Yang W, Guan H.
europepmc   +1 more source

Real-World Epidemiology, Clinical Characteristics and Outcomes of Women with Germline BRCA Mutation and Early Breast Cancer in China. [PDF]

Oncol Ther
Hu Z, Yu Q, Chen L, Su T, Berrocal-Almanza LC, Miranda M, Xu X, Ru M, Zhao T, Miao F, Xie M, Shao Z.   +11 more
europepmc   +1 more source

Risk-Reducing Breast and Gynecological Surgery for BRCA Mutation Carriers: A Narrative Review. [PDF]

J Clin Med, 2023
Bertozzi S, Londero AP, Xholli A, Azioni G, Di Vora R, Paudice M, Bucimazza I, Cedolini C, Cagnacci A.   +8 more
europepmc   +1 more source

A Phase II Pilot Study of Anti-PD-L1, Durvalumab, and a PARP Inhibitor, Olaparib in Patients With Metastatic Triple-Negative Breast Cancer With or Without Germline BRCA Mutation. [PDF]

Cancer Med
Fujii T, Cimino-Mathews A, Lipkowitz S, Lee MJ, Nair J, Solarz BB, Zimmer A, Redd B, Levy EB, Rastogi S, Sato N, McCoy A, Steinberg SM, Lee JM.   +13 more
europepmc   +1 more source

BRCA mutation and multiple primary malignancies: a rare case of recurring triple-negative breast cancer and cervical cancer. [PDF]

Ecancermedicalscience
Naciri M, Aouzah FE, El Ghanmi A, Ghazi B, Fichtali K, Mohammed SH, Kouhen F.   +6 more
europepmc   +1 more source

Development of a circHIPK3-based ceRNA network and identification of mRNA signature in breast cancer patients harboring BRCA mutation. [PDF]

PeerJ, 2023
Lian QX, Song Y, Han L, Wang Z, Song Y.
europepmc   +1 more source

Successful Combination of Olaparib and ²²⁵Ac-Dotatate in a Patient with Neuroendocrine Tumor G3 and BRCA Mutation. [PDF]

Case Rep Oncol, 2023
Kröcher A, Folprecht G, Winzer R, Sergon M, Bornhäuser M, Kotzerke J, Brogsitter C.   +6 more
europepmc   +1 more source

Olaparib Monotherapy or in Combination with Abiraterone for the Treatment of Patients with Metastatic Castration-Resistant Prostate Cancer (mCRPC) and a BRCA Mutation. [PDF]

Target Oncol
Saad F, Armstrong AJ, Shore N, George DJ, Oya M, Sugimoto M, McKay RR, Hussain M, Clarke NW.   +8 more
europepmc   +1 more source